Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors

NCT00002587 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: paclitaxel
DRUG: topotecan hydrochloride

Sponsor

National Cancer Institute (NCI)